Thrombosis: Difference between revisions
Jump to navigation
Jump to search
Kiran Singh (talk | contribs) |
|||
| Line 26: | Line 26: | ||
[[Thrombosis risk factor modifications|Risk Factor Modifications]] | [[Thrombosis prevention|Prevention]] | [[Thrombosis risk factor modifications|Risk Factor Modifications]] | [[Thrombosis prevention|Prevention]] | ||
====Contraindicated medications==== | ====Contraindicated medications==== | ||
Revision as of 15:08, 2 December 2014
|
Thrombosis Microchapters |
|
Site of Thrombosis |
|---|
|
Differentiating Thrombosis from other Diseases |
|
Diagnosis |
|
Treatment |
|
Thrombosis On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Classification
Arterial | Venous | Arterial and Venous Thrombosis: Differences and Similarities
Causes
Site of Thrombosis
Differentiating Thrombosis from other Diseases
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Treatment
Risk Factor Modifications | Prevention
Contraindicated medications
Deep vein thrombosis is considered an absolute contraindication to the use of the following medications:
- Ethynodiol diacetate and ethinyl estradiol
- Norethindrone acetate and Ethinyl estradiol
- Norgestimate and Ethinyl estradiol
- Norgestrel and Ethinyl estradiol